These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2468983

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Clofazimine therapy for lepromatous leprosy: a historical perspective.
    Fajardo TT, Abalos RM, dela Cruz EC, Villahermosa LG, Walsh DS, Cellona RV, Balagon MV, Tan EV, Walsh GP.
    Int J Dermatol; 1999 Jan; 38(1):70-4. PubMed ID: 10065616
    [No Abstract] [Full Text] [Related]

  • 50. On the value of sequential serology with a Mycobacterium leprae-specific antibody competition ELISA in monitoring leprosy chemotherapy.
    Chaturvedi V, Sinha S, Girdhar BK, Sengupta U.
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):32-40. PubMed ID: 2030315
    [Abstract] [Full Text] [Related]

  • 51. Primary involvement of penile skin in lepromatous leprosy.
    Mukhopadhyay AK.
    Indian J Lepr; 2005 Mar; 77(4):317-21. PubMed ID: 16465827
    [Abstract] [Full Text] [Related]

  • 52. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP, Wakade A, Antia NH.
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH, Ji BH, Guelpa-Lauras CC, Perani EG, N'Deli LN.
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [Abstract] [Full Text] [Related]

  • 55. Wade's histoid leprosy: three clinical presentations.
    Pereyra SB, Danielo CA, Ponssa GJ, Consigli JE, Papa MB, Ghirardi G.
    Int J Dermatol; 2007 Sep; 46(9):944-6. PubMed ID: 17822497
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Clinical aspects of leprosy.
    Talhari C, Talhari S, Penna GO.
    Clin Dermatol; 2015 Sep; 33(1):26-37. PubMed ID: 25432808
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.